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aBstraCt
BaCKground: Cataract increases intraocular light scatter which affects the retinal image contrast and sensitivity. 
Symptomatic patients with cataract complain of a drop in the quality of vision or glare affecting daily routine even 
with preserved visual acuity. This study was aimed to quantify the drop in the glare induced visual acuity (VA) and 
contrast sensitivity (CS) in different morphological types of cataracts.
Material and Methods: This was an observational study on a prospective cohort, conducted at a tertiary-care 
centre in South-India. Patients admitted for cataract surgeries between March and September 2017 with BCVA ≥ 
6/60 (Snellen) and ≥ 40 years were enrolled. LogMAR VA and CS were measured pre and post-operatively, with and 
without glare induction using brightness acuity tester. Patients were sub-categorised based on morphology and the 
presence of glare as a symptom. Paired-t test for the pre- and post-operative values and analysis with Bonferroni’s 
adjustment were the statistical methods used.
results: Data of 78 patients were sub-categorised and analysed. Glare induction with high glare was significant in 
all the studied groups. LogMAR VA was affected most in group 3 (0.20, 10 letters, p < 0.05) and the CS in group 
2 (0.62, 4.1 step drop, p < 0.05). Patients who had glare as a symptom had an average greater drop in LogMAR VA 
(0.30, p = 0.01) and CS (–0.29, p = 0.03) when induced with a high glare. 
ConClusions: All morphological types of cataracts affect VA and CS to a greater extent in conditions of bright 
lighting. Glare induced VA and CS testing is a sensitive and an adjunct tool to traditional high contrast VA testing, 
in evaluating the visual dysfunction of patients presenting with symptomatic cataracts.
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introduCtion
Visual acuity (VA) is a special sense and a de-
crease in which can result in difficulties of all func-
tional domains of day-today activities. The visual 
experience of a human eye is not just isolated to 
the VA alone but involves the various attributes of 
vision [1–3]. The physiology of the visual system 
is a series of complex tasks, which includes the 
transmission of visual sensations forming represen-
tations, stereopsis, perception of movement, colour 
vision, contrast perception etc [1–6].
Ocular pathologies with media opacity lead to 
light scattering resulting in glare and affects the con-
trast of the visual scene for the individual. Contrast 
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sensitivity (CS) is the ability to discern and detect an 
object against its background whereas glare is the con-
trast reducing effect secondary to stray light in the vis-
ual scene [7–9]. Individual variations are seen with CS 
and it physiologically declines with age whereas glare 
could become bothersome depending on its severity 
and the individual needs. Cataract is the most com-
mon condition which results in increased intraocular 
light scatter affecting the CS and thereby the quality 
of the visual perception and the image [10–14]. Visual 
acuity though is the traditional standard measure of 
visual function, is retained till advance stages of cata-
racts, even in the presence of other visual complaints 
[14, 15] The advice on surgery largely depends on the 
measured VA in most hospitals and has become the 
sole criteria to advice the patient. 
A brightness acuity tester (BAT) with a stand-
ardized glare induction can measure the drop in 
glare-induced VA and CS [16, 17]. A measure of 
these parameters when compared to the post-op-
erative recovery will provide information about the 
visual disability of the patients, which retrospec-
tively will quantify as the extent of visual quality 
deterioration. In our study, we evaluated and quan-
tified glare induced degradation of VA (LogMAR 
— logarithm of the minimum angle of resolution) 
and CS (Pelli-Robson chart) in patients who were 
admitted for cataract surgeries.
Material and Methods 
This was an observational study on a prospective 
cohort of patients, conducted at a tertiary care cen-
tre in southern India between March and Septem-
ber 2017. The study was approved by the Institu-
tional Review Board and the Ethics Committee and 
followed the Tenets of the Declaration of Helsinki.
saMple size CalCulation
We needed to study 77 patients (eyes) to study 
a difference of 0.8 between the pre and post-opera-
tive (90% power at a 5% level of significance). The 
sample size was calculated based on the study by 
Wood et al [18]. We enrolled 90 patients with an 
assumption of about 15–20% as the drop-out rate 
during follow up.
enrollMent
Patients admitted for cataract surgeries during 
the study period were enrolled after informed con-
sent. Demographic data and symptomatology per-
taining to cataract affecting their daily routine were 
collected. Patients with best corrected visual acuity 
(BCVA) of Snellen equivalent of 6/60 or better, 
and above 40 years with the ability to read English 
alphabets were identified and included in the study. 
Patients with corneal degenerations, dystrophies or 
scars in the visual axis, synechiae and abnormalities 
of pupil, retinal and optic nerve pathologies were 
excluded. Other exclusion criteria included were the 
usage of dilating drops in the preceding 48 hours 
and dilated or non-reacting pupil as these could 
exaggerate the glare perception. 
Methodology
All patients who were enrolled underwent BCVA 
measurement with LogMAR chart (Weber contrast 
97%, Appasamy I Chart Lite, 100 cd/m2) by the 
primary investigator. Patients had their CS measure-
ment with the Pelli-Robson chart (3 m, 80 cd/m2) 
following which the LogMAR vision and CS were 
measured again in low-glare (10 foot-lamberts) and 
high-glare (100 foot-lamberts) respectively using 
a BAT (Marco, BAT-2000, Jacksonville, Florida) by 
the co-investigator. The horizontal pupillary diam-
eter was then measured (NIDEK Optical Biometry, 
Nidek CO., Ltd., Japan Model 2000) under normal 
room lighting conditions (LUX 32 cd/m2) by the pri-
mary investigator. The luminance was measured with 
the Secure Life Illumination meter (Class B per DIN 
5032-7, Gossen Mavolux Ltd.). Patients were exam-
ined for the type and the morphology of the cataract 
by a single ophthalmologist (Slit-lamp, HAAG Streit, 
International 10) using LOCS III (Lens Opacities 
Classification System III). To avoid observation bias, 
the measurements were done independently and all 
three investigators were blinded from each other’s 
readings. Patients underwent their planned surger-
ies and all the readings were repeated with the same 
protocol at the scheduled follow up visit between 
6 ± 1 weeks following their cataract surgeries. Fur-
ther, at follow up, the resolution of the symptoms 
were recorded in a Likert Scale of 0 to 10 with 10 be-
ing the complete resolution of the same. 
statistiCal analysis
Data was entered into Microsoft Excel and 
analysed using STATA/IC 13.1. Data was sum-
marised using mean (standard deviation) for con-
tinuous variables and frequency (%) for categorical 
variables. Continuous variables were analysed using 
ANOVA, categorical variables using paired-t-test 
for pre and post-operative differences and statistical 
significance kept at 5% level (p < 0.05). Bonferroni 
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correction adjustment was applied for the analysis 
of the measured values between groups.
results
Ninety patients were enrolled in the study of 
which 12 patients did not follow up as per the study 
protocol as defined in the study; data of 78 patients 
were analysed. The mean age of the participants 
was 61.68 years (range 41–80 years). Primary com-
plaints were either decreased vision or glare with 
47 patients in our study population had both the 
symptoms. Almost 70% of our study population 
(54 patients) experienced glare from the headlamps 
of the oncoming vehicles or on exposure to bright 
sunlight. Of the patients who had glare, 20 patients 
drove vehicles on a regular basis, and all of them 
experienced troubling glare from headlights of the 
oncoming vehicles. Forty-six of the 54 patients who 
had symptoms of glare had a component of poste-
rior sub-capsular cataract. All except three patients 
had a complete reduction of glare postoperatively, 
and the three patients had reported a score of 5 on 
a Likert Scale of 0 to 10 for reduction of glare 
post-operatively. The evaluation revealed two pa-
tients having minimal residual central striate kerat-
opathy involving the pupillary axis and one with 
an IOL dislocation with a fixed mid-dilated pupil 
of 4.1 mm, as the possible reasons for the residual 
complaints of glare.
Patients were grouped based on the morpho-
logical type of cataracts — nuclear sclerosis (NS) 
— Group 1 (20 patients, 25.64%), posterior capsule 
cataract (PSC) — Group 2 (11 patients, 14.10%) 
and a combination of nuclear sclerosis with poste-
rior capsule cataract (NS + PSC, Group 3, 47 pa-
tients, 60.26%). Presence of cortical opacities in the 
central 3 mm zone (visual axis) was also noted. The 
mean pre-operative horizontal pupillary diameter 
as measured with Optical Biometer, was 2.87 mm 
(SD ± 0.08) and post-operatively was 3.17 mm 
(SD ± 0.08) and the mean difference of 0.3 mm 
between the subgroups was clinically negligible and 
not statistically significant.
Table 1 gives an overview of the raw data of 
the mean values of the LogMAR and the CS val-
table 1. raw data of the mean values of the logMar and contrast sensitivity (Cs) induced with low and high-glare with 
the brightness acuity tester in the various study groups
logMar Vision
logMar vision  
in low glare
logMar vision  
in high glare
Contrast 
sensitivity
Contrast 
sensitivity  
in low glare
Contrast 
sensitivity  
in high glare
preoperative measurements 
Mean values (± sd)
group 1
(n = 20)
0.35 (0.15) 0.36 (0.13) 0.51 (0.26) 1.11 (0.32) 1.10 (0.33) 0.61 (0.41)
group 2
(n = 11)
0.37 (0.24) 0.38 (0.24) 0.51 (0.44) 1.03 (0.39) 1.02 (0.39) 0.41 (0.51)
group 3
(n = 47)
0.52 (0.22) 0.53 (0.21) 0.72 (0.35) 0.80 (0.38) 0.79 (0.40) 0.26 (0.33)
Total
(n = 78)
0.46 (0.22) 0.46 (0.22) 0.64 (0.36) 0.91 (0.40) 0.91 (0.41) 0.37 (0.41)
post-operative measurements
Mean values (± sd)
group 1
(n = 20)
0.08 (0.11) 0.08 (0.11) 0.11 (0.13) 1.52 (0.25) 1.52 (0.25) 1.29 (0.26)
group 2
(n = 11)
0.09 (0.16) 0.08 (0.15) 0.10 (0.16) 1.60 (0.16) 1.56 (0.12) 1.47 (0.22)
group 3
(n = 47)
0.10 (0.11) 0.10 (0.11) 0.10 (0.13) 1.43 (0.24) 1.44 (0.24) 1.27 (0.23)
Total
(n = 78)
0.10 (0.12) 0.10 (0.12) 0.11 (0.14) 1.48 (0.24) 1.49 (0.24) 1.31 (0.25)
SD — standard deviation
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ues among the three morphological groups pre and 
post-surgery, with and without the induction of 
glare with BAT. Similarly, Table 2 shows the mean 
values of the patients pre and post-surgery catego-
rised with the presence or absence of glare. All values 
of LogMAR or CS in different situations of induc-
tion with BAT not only were statistically significant 
but were also clinically significant. Figure 1 shows 
the mean improvement in the LogMAR and CS 
following surgery as compared to the pre-operative 
values, with and without induction with low and 
high glare respectively. Table 3 shows the Odd’s 
table 2. Mean pre-operative logMar and contrast sensitivity (Cs) values pre subcategorised with a glare as a symptom 
at presentation
pre-operative values
glare as a symptom at presentation
present (n = 53) 
Mean (± sd)
absent (n = 25) 
Mean (± sd)
difference 
(p value)
logMar vision 0.51 (0.21) 0.35 (0.20) 0.16 (0.04)
logMar vision in low glare 0.51 (0.21) 0.37 (0.19) 0.14 (0.05)
logMar vision in high glare 0.70 (0.35) 0.40 (0.18) 0.30 (0.01)
Contrast sensitivity 0.85 (0.39) 1.04 (0.42) –0.19 (0.04)
Contrast sensitivity in low glare 0.84 (0.38) 1.03 (0.43) –0.19 (0.04)
Contrast sensitivity in high glare 0.30 (0.37) 0.59 (0.45) –0.29 (0.03)
table 3. odds ratio of the presence of glare as a symptom to the various morphological types of cataracts in the study 
population
glare vs. cortical 
riders
glare vs. ns 
(group 1)
glare vs. psC alone 
(group 2)
glare vs. ns + psC 
(group 3)
glare vs. presence 
of psC
odds ratio 1.2209 0.1926 1.3037 3.4688 5.1923
Confidence interval 
(95%)
0.342–4.354 0.065–0.570 0.134–5.401 1.282–9.351 1.75–15.39
NS — nuclear sclerosis; pSC — posterior subcapsular cataract
Figure 1. Difference between the pre and post-operative values of the logMar vision and the contrast sensitivity with and without 
induction of low glare (lg) and high glare (Hg)
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ratio of glare to the presence of the morphologi-
cal characteristics of the cataract to assess the risk 
of having glare as a symptom associated with the 
presence of it. The presence of either cortical riders 
or PSC is shown to have the associated risk of glare 
with the presence of PSC alone, showing a 5 fold 
risk association.
disCussion
Discomforting or the disabling glare in the vis-
ual scene results in sub-optimal visual performance. 
Disability glare due to light scatter or discomfort-
ing glare resulting in an instinctive desire to look 
away from the light source, both of which can be 
distracting and blinding in extreme situations. Light 
scattering is a normal consequence of the aging 
process, which leads to a patient having a decreased 
retinal contrast and glare disability [12–15]. Pres-
ence of cataractous changes in the lens, increases the 
intraocular light scatter and thereby reduces retinal 
image contrast and degradation of visual quality 
[15–17]. There is no defined cut-off of BCVA to 
define cataract, although symptomatic patients can 
complain of glare even without any drop in the 
measured vision [15]. Patients with significant cata-
ractous change often deal with glare on a daily basis 
which can be unpleasant depending on the visual 
needs and demands of the individual.
Cataracts of all types theoretically can drop VA 
and CS in situations that induce glare [19–23]. 
The difference between the mean LogMAR vision 
and CS-induced with a high glare in our study 
population, showed a statistically significant differ-
ence between the pre and post-operative values ir-
respective of the sub-groups and the morphological 
types (Tab. 1, Fig. 1). However, this difference was 
not significant between the pre and post-operative 
values on induction with low glare. Though glare 
disability could act as an adjunct tool to VA meas-
urement to advice on cataract surgery, the visual 
need of the varies with individuals [20, 23]. The 
tropical sunny climate of South India and with 
most patients in our study from an agricultural 
background is likely the reason for nearly 70% of 
our study patients complaining of glare as a symp-
tom. In real-life situations, working in fields under 
a sunny climate of a tropical region or being on 
a sunny beach can be considered equivalent to high 
glare induction [16, 17]. Though CS and LogMAR 
vision assessment with and without glare induction 
provide useful information on the visual disability 
in day-today activities, neither is quantified in dif-
ferent types of morphological cataracts to advise 
patients on the requirement of surgery.
All morphological forms of cataract are reported 
to cause glare disability to varied extents. From clini-
cal experience, one would anticipate patients with 
PSC to have the maximum effect on the vision when 
induced with glare [12, 21, 22]. This is evident in 
our study as well where the glare induced VA and CS 
in Group 2 and 3 had the highest drop. However, 
when the patients with glare were compared with 
the ones who did not complain of glare, the VA 
and CS showed a statistically significant difference 
in the measure values (Tab. 2). This difference was 
greater when induced with high glare and was sta-
tistically and clinically more significant. Moreover, 
the recovery of the VA and CS following surgery 
in simulated testing (induced glare) conditions, are 
indirect measures of the glare disability in day today 
activities. Studies have reported a significant drop 
of CS in patients even with the presence of milder 
forms of PSC [19, 21, 22] again a consistent find-
ing as seen in our study with Group 2 (PSC alone). 
Brightness acuity tester in conjunction with CS has 
been reported to be more sensitive than VA alone 
especially with VA ≥ 20/80 [8, 18, 21]. The odds of 
having glare as a symptom in our study was the high-
est in patients with PSC, and is again the highest in 
our study, as seen to be three to five times in these 
patients (Tab. 3). The strong influence of the PSC to 
the visual symptoms resulting in decreased VA and 
impairment of CS can be attributed to the proximity 
of the location of PSC to the nodal point. 
In real-life situations, one would expect a combi-
nation of NS with PSC to affect the CS more than 
either of the morphology alone. In our study popu-
lation, the LogMAR vision seems most affected in 
group 3, whereas it is less affected with a similar pat-
tern in the other two morphological groups (Fig. 1). 
Similarly, CS is affected most in Group 2 (presence 
of PSC only) and group 3 (PSC in association with 
NS), as compared by NS alone (Group 1) (Fig. 1). 
Majority of patients (47 patients, 60.3%) in our 
study had a combination of NS with PSC, which is 
a true representation of the distribution of patients 
seeking surgery in routine practice [22, 24, 25]. 
When induced with high glare, Group 1 had a drop 
in the LogMAR (0.16) and CS (0.50), Group 2 with 
LogMAR (0.14) and CS (0.62) and Group 3 had 
a drop in LogMAR (0.20) and CS (0.54) respective-
ly (Tab. 1). With each letter valued to be 0.02 units 
in LogMAR assessment, an average drop of about 
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9 letters (p < 0.05) is evident in our study popula-
tion (Tab. 1). This is equivalent to a 2 lines drop 
in LogMAR VA assessment, which is clinically 
significant in any testing conditions. Similarly, an 
average of 0.54 drop in the CS, translates to around 
3.6 (p < 0.05) step drop with the Pelli-Robson 
chart in our study population. This deterioration 
on induced glare testing is clinically significant and 
could be extremely bothersome to the patients in the 
day-today activities. Though the change in the values 
in the three groups are linear with the induction of 
high glare, the visual degradation of LogMAR VA 
and the CS are not similar and may not be to the 
same extent. In a clinical setup and in the evaluation 
of the patients towards cataract surgeries, both glare 
induced VA and CS have its advantages to quantify 
the change and one cannot be ignored over the in-
formation obtained from the other.
Symptomatic patients with a significant drop 
in the CS but not with LogMAR are the group of 
patients seem to present late in the course of the 
disease. With slow progress in cataractous changes, 
the individual may fail to notice the change in the 
quality of the image. This probably is because such 
patients are getting neuro-acclimatised over time 
and the sensory image may be regarded as “accept-
ably clear” due to gradual habituation and tolerance 
of the individual. The glare induced VA and CS 
drop, simulate the real-life scenarios of patients with 
symptomatic cataracts, and would better correlate 
to the symptoms to advise patients with visual dis-
ability. The patients with reasonably good pre-oper-
ative VA and have opted for surgery had the greatest 
drop in their CS ascertains the fact stronger. Since 
our sample only included patients who presented 
for surgery, it may be interpreted vice versa. This 
retrospectively suggests that the additional contri-
bution of cataract to the glare and why the patients 
are symptomatic despite a good measured VA.
To quantify the quality of vision by a single pa-
rameter is often difficult and this statistically signifi-
cant effect of cataract in the vision parameters sup-
ports the clinical relevance of measuring the same 
with glare induction [15, 17, 21]. It would be pru-
dent to test glare induced VA and CS degradation 
along with the routine vision assessment, which will 
help us to understand the symptomatology better in 
patients presenting with symptoms of cataract. Test-
ing VA and CS with BAT in patients who request 
surgery at good levels of vision can give us a better 
insight into why these patients want surgery and to 
understand the visual change characteristics. A drop 
in vision on induced glare testing among such pa-
tients can then justify advising surgery. However, it 
is not true otherwise, to use BAT testing to justify 
cataract surgery in patients who have do not have 
symptoms. VA and CS degradation with glare in-
duction will act as more sensitive methods of testing 
visual function than the routine measurements of 
the high contrast based VA measurements alone. 
Done routinely, glare testing will predict real-life 
visual disability better in patients who have cataracts 
with symptoms.  
Limitation of our study includes evaluating with 
our working conditions, which were possibly dif-
ferent the other studies (as all the studies have not 
reported the ambient intensity), which could have 
altered the absolute value of BAT. Our study in-
cluded only patients admitted for cataract surgeries 
and hence extrapolation of these observations to 
a general population should be done with caution 
as this may not represent the true distribution of an 
epidemiological cataract population. 
ConClusions
Cataracts affect vision and contrast to a greater 
extent in conditions of high glare and bright lighting. 
The presence of PSC either alone or in combination 
with NS has a significant effect on the glare induced 
CS as well as the VA of an individual. Performing 
a glare induced VA and CS testing in patients pre-
senting with cataracts for advice, are sensitive ancil-
lary measurements that will simulate real-life situa-
tions and will provide a comprehensive assessment of 
vision disability affecting the daily routine. 
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